201 related articles for article (PubMed ID: 29224713)
1. Veterinary Oncology Immunotherapies.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):257-277. PubMed ID: 29224713
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in veterinary oncology.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):925-39. PubMed ID: 25174908
[TBL] [Abstract][Full Text] [Related]
3. Cancer Immunotherapies.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):881-902. PubMed ID: 31186125
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy.
Bergman PJ
Top Companion Anim Med; 2009 Aug; 24(3):130-6. PubMed ID: 19732731
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapy.
Bergman PJ
Vet Clin North Am Small Anim Pract; 2010 May; 40(3):507-18. PubMed ID: 20471533
[TBL] [Abstract][Full Text] [Related]
6. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology.
Marconato L; Buracco P; Aresu L
Vet J; 2015 Aug; 205(2):238-43. PubMed ID: 25862396
[TBL] [Abstract][Full Text] [Related]
8. Are peptide vaccines viable in combination with other cancer immunotherapies?
Ohtake J; Sasada T
Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424
[No Abstract] [Full Text] [Related]
9. Cancer immunotherapy for the veterinary patient.
Biller BJ
Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1137-49; vii. PubMed ID: 17950887
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
[TBL] [Abstract][Full Text] [Related]
11. Challenges and opportunities for monoclonal antibody therapy in veterinary oncology.
Beirão BC; Raposo T; Jain S; Hupp T; Argyle DJ
Vet J; 2016 Dec; 218():40-50. PubMed ID: 27938708
[TBL] [Abstract][Full Text] [Related]
12. Neoantigens in the immuno-oncology space.
Arlen PM
Future Oncol; 2017 Oct; 13(25):2209-2211. PubMed ID: 28976211
[No Abstract] [Full Text] [Related]
13. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
14. Preface: More than two decades of modern tumor immunology.
Galluzzi L; Rudqvist NP
Methods Enzymol; 2020; 632():xxiii-xlii. PubMed ID: 32000917
[No Abstract] [Full Text] [Related]
15. Immunotherapy for canine cancer--is it time to go back to the future?
Killick DR; Stell AJ; Catchpole B
J Small Anim Pract; 2015 Apr; 56(4):229-41. PubMed ID: 25704119
[TBL] [Abstract][Full Text] [Related]
16. Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?
Manjili MH; Payne KK
Discov Med; 2015 Jun; 19(107):427-31. PubMed ID: 26175400
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in cancer immunology and immunology-based anticancer therapies.
Kumar S; Saini RV; Mahindroo N
Biomed Pharmacother; 2017 Dec; 96():1491-1500. PubMed ID: 29198747
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
Fry TJ; Lankester AC
Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
[TBL] [Abstract][Full Text] [Related]
19. A Theoretical Basis for the Efficacy of Cancer Immunotherapy and Immunogenic Tumor Dormancy: The Adaptation Model of Immunity.
Manjili MH
Adv Cancer Res; 2018; 137():17-36. PubMed ID: 29405975
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches in cancer immunotherapy -- a light at the end of the tunnel.
Joshi M; Pal SK; Drabick JJ
Discov Med; 2016 Jun; 21(118):479-87. PubMed ID: 27448784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
